Nephrogenic Systemic Fibrosis

Jeffrey C. Weinreb, Phillip H. Kuo

Research output: Contribution to journalReview articlepeer-review

30 Scopus citations


There seems to be an association between exposure to intravenous gadolinium-based contrast agents (GBCAs) and nephrogenic systemic fibrosis (NSF), a debilitating and sometimes fatal disease. This article addresses the relationship between GBCAs and NSF and answers some common questions. The policy deployed at Yale-New Haven Hospital for prevention of NSF and screening for patients at risk is delineated and discussed along with recommendations by the Food and Drug Administration.

Original languageEnglish (US)
Pages (from-to)159-167
Number of pages9
JournalMagnetic resonance imaging clinics of North America
Issue number1
StatePublished - Feb 2009


  • Gadolinium
  • Gadolinium chelates
  • Gadolinium-based contrast agent
  • MR contrast agents
  • MR imaging
  • Nephrogenic systemic fibrosis

ASJC Scopus subject areas

  • Radiology Nuclear Medicine and imaging


Dive into the research topics of 'Nephrogenic Systemic Fibrosis'. Together they form a unique fingerprint.

Cite this